Log In
Print this Print this

BMS-852927 (formerly XL041)

  Manage Alerts
Collapse Summary General Information
Company Exelixis Inc.
DescriptionSmall molecule modulator of the Liver X receptor (LXR
Molecular Target Liver X receptor (LXR)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationMetabolic syndrome
Indication DetailsTreat metabolic syndrome
Regulatory Designation
PartnerBristol-Myers Squibb Co.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today